ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Trastuzumab is on this study

  • No treatment in the record names it; a reading of the whole record found it given.
  • Claude Opus 5.5 judged it a tool of the study (an imaging tracer, a test of drug response). Nov 2, 2026, 3:40 AM UTC“Radiolabelled as a PET tracer in esophagogastric cancer”
  • The role rule had no answer: no treatment entry names it.
  • So Trastuzumab's page lists this study under “As a tool”.
1 links1 made here, not in the record1 judgments1 judge (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Record updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT02023996PET Imaging With89Zr-DFO-Trastuzumab inEsophagogastric CancerMemorial Sloan Kettering CanceNA · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedDRUGSTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · ProcedureProcedure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Trastuzumabmade hereClaude Opus 5.5ProcedureCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change